Virtus Biotech Clinical TriaBBCETF
13F holders, Q2 2024 (June 30)14holders −3
1new positions
4sold out
1famous investor
$25.26avg. 13F price*
At the end of Q2 2024, 14 institutions reported holding Virtus Biotech Clinical Tria (BBC) in their 13F filings, down 3 from Q1 2024. 1 opened new positions and 4 sold out. The largest holders were Citadel Advisors ($1.0M), Susquehanna International Group, LLP ($847K) and Morgan Stanley ($538K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Virtus Biotech Clinical Tria
- Filed as
- ETFIS SER TR I (Q2 2024)
- CUSIP
- 26923G301
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $1.0M |
| Exits | 4 | $44K |
All 13F filers, Q1 2024 → Q2 2024: 61,277 shares bought and 22,451 shares sold, net +38,826 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Citadel Advisors | 0.00% | New | 40,100 | $1.0M |
| Susquehanna International Group, LLP | 0.00% | Add +171.2% | 33,544 | $847K |
| Morgan Stanley | 0.00% | Reduce -47.1% | 21,299 | $538K |
| LPL Financial LLC | 0.00% | Reduce -11.7% | 12,716 | $321K |
| US Bancorp \de | 0.00% | No change | 1,000 | $25K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 838 | $21K |
| Dynamic Wealth Strategies, LLC | 0.02% | No change | 802 | $20K |
| Osaic Holdings, Inc. | 0.00% | No change | 447 | $11K |
| Harbour Investments, Inc. | 0.00% | No change | 310 | $8K |
| Baldwin Wealth Partners LLC | 0.00% | No change | 100 | $3K |
| Global Retirement Partners, LLC | 0.00% | No change | 44 | $1K |
| Comerica Bank | 0.00% | Reduce -87.6% | 35 | $884 |
| Allworth Financial LP | 0.00% | No change | 10 | $278 |
| NewEdge Advisors, LLC | 0.00% | No change | 5 | $126 |
"% of holder's portfolio" is BBC's weight in each manager's 13F, not the share of Virtus Biotech Clinical Tria the manager owns.